{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:27:58Z","timestamp":1791822478814,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10072-020-04707-9","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T22:02:53Z","timestamp":1601589773000},"page":"2031-2037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke"],"prefix":"10.1007","volume":"42","author":[{"given":"Maria","family":"Balea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Codruta","family":"Birle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezara","family":"Costin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Marton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Anamaria","family":"Muresanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Jemna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Livint","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Slavoaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia Verisezan","family":"Rosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Stan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitalie","family":"Vacaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Strilciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-1153","authenticated-orcid":false,"given":"Dafin F.","family":"Muresanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"4707_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12916-019-1397-3","volume":"17","author":"A Avan","year":"2019","unstructured":"Avan A, Digaleh H, Di Napoli M et al (2019) Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med 17:191\u2013191. https:\/\/doi.org\/10.1186\/s12916-019-1397-3","journal-title":"BMC Med"},{"key":"4707_CR2","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1212\/WNL.0000000000007936","volume":"93","author":"B Cucchiara","year":"2019","unstructured":"Cucchiara B, George DK, Kasner SE, Knutsson M, Denison H, Ladenvall P, Amarenco P, Johnston SC (2019) Disability after minor stroke and TIA: a secondary analysis of the SOCRATES trial. Neurology 93:e708\u2013e716. https:\/\/doi.org\/10.1212\/WNL.0000000000007936","journal-title":"Neurology"},{"key":"4707_CR3","doi-asserted-by":"publisher","first-page":"104450","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104450","volume":"28","author":"RM Shavelle","year":"2019","unstructured":"Shavelle RM, Brooks JC, Strauss DJ, Turner-Stokes L (2019) Life expectancy after stroke based on age, sex, and rankin grade of disability: a synthesis. J Stroke Cerebrovasc Dis 28:104450. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.104450","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4707_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovi\u0107","year":"2017","unstructured":"Mijajlovi\u0107 MD, Pavlovi\u0107 A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, Kliper E, Shin YI, Kim YH, Choi SH, Jung S, Lee YB, Sinanovi\u0107 O, Levine DA, Schlesinger I, Mead G, Milo\u0161evi\u0107 V, Leys D, Hagberg G, Ursin MH, Teuschl Y, Prokopenko S, Mozheyko E, Bezdenezhnykh A, Matz K, Aleksi\u0107 V, Muresanu DF, Korczyn AD, Bornstein NM (2017) Post-stroke dementia - a comprehensive review. BMC Med 15:11\u201311. https:\/\/doi.org\/10.1186\/s12916-017-0779-7","journal-title":"BMC Med"},{"key":"4707_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnagi.2013.00017","volume":"5","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013) Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci 5:17\u201317. https:\/\/doi.org\/10.3389\/fnagi.2013.00017","journal-title":"Front Aging Neurosci"},{"key":"4707_CR6","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1212\/01.wnl.0000115108.65264.4b","volume":"62","author":"PS Sachdev","year":"2004","unstructured":"Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi JCL, Wen W, Zagami AS (2004) The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62:912\u2013919. https:\/\/doi.org\/10.1212\/01.wnl.0000115108.65264.4b","journal-title":"Neurology"},{"key":"4707_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2015.04.022","volume":"354","author":"P S\u00f6r\u00f6s","year":"2015","unstructured":"S\u00f6r\u00f6s P, Harnadek M, Blake T, Hachinski V, Chan R (2015) Executive dysfunction in patients with transient ischemic attack and minor stroke. J Neurol Sci 354:17\u201320. https:\/\/doi.org\/10.1016\/j.jns.2015.04.022","journal-title":"J Neurol Sci"},{"key":"4707_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/STROKEAHA.112.670844","volume":"44","author":"A Douiri","year":"2013","unstructured":"Douiri A, Rudd AG, Wolfe CDA (2013) Prevalence of poststroke cognitive impairment: South London Stroke Register. Stroke 44:138\u2013145. https:\/\/doi.org\/10.1161\/STROKEAHA.112.670844","journal-title":"Stroke"},{"key":"4707_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/gps.2573","volume":"26","author":"C Guti\u00e9rrez P\u00e9rez","year":"2011","unstructured":"Guti\u00e9rrez P\u00e9rez C, S\u00e4vborg M, P\u00e5hlman U, Cederfeldt M, Knopp E, Nordlund A, \u00c5strand R, Wallin A, Fr\u00f6jd K, Wijk H, Tarkowski E (2011) High frequency of cognitive dysfunction before stroke among older people. Int J Geriatr Psychiatry 26:622\u2013629. https:\/\/doi.org\/10.1002\/gps.2573","journal-title":"Int J Geriatr Psychiatry"},{"key":"4707_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3978\/j.issn.2305-5839.2014.08.05","volume":"2","author":"J-H Sun","year":"2014","unstructured":"Sun J-H, Tan L, Yu J-T (2014) Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med 2:80\u201380. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.05","journal-title":"Ann Transl Med"},{"key":"4707_CR11","doi-asserted-by":"publisher","first-page":"e22036","DOI":"10.1002\/syn.22036","volume":"72","author":"EM Hern\u00e1ndez-Hern\u00e1ndez","year":"2018","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez EM, Caporal Hernandez K, V\u00e1zquez-Roque RA, D\u00edaz A, de la Cruz F, Flor\u00e1n B, Flores G (2018) The neuropeptide-12 improves recognition memory and neuronal plasticity of the limbic system in old rats. Synapse 72:e22036. https:\/\/doi.org\/10.1002\/syn.22036","journal-title":"Synapse"},{"key":"4707_CR12","first-page":"207","volume":"8","author":"B Hutter-Paier","year":"2015","unstructured":"Hutter-Paier B, Reininger-Gutmann B, Wronski R, Doppler E, Moessler H (2015) Long-term treatment of aged Long Evans rats with a dietary supplement containing neuroprotective peptides (N-PEP-12) to prevent brain aging: effects of three months daily treatment by oral gavage. J Med Life 8:207\u2013212","journal-title":"J Med Life"},{"key":"4707_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00702-005-0283-7","volume":"112","author":"M Windisch","year":"2005","unstructured":"Windisch M, Hutter-Paier B, Grygar E, Doppler E, Moessler H (2005) N-PEP-12 \u2013 a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. J Neural Transm 112:1331\u20131343. https:\/\/doi.org\/10.1007\/s00702-005-0283-7","journal-title":"J Neural Transm"},{"key":"4707_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1358\/mf.2005.27.7.914776","volume":"27","author":"XA Alvarez","year":"2005","unstructured":"Alvarez XA, Corzo L, Laredo M et al (2005) Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjects. Methods Find Exp Clin Pharmacol 27:483\u2013487. https:\/\/doi.org\/10.1358\/mf.2005.27.7.914776","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"4707_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004850-200503000-00006","volume":"20","author":"TH Crook","year":"2005","unstructured":"Crook TH, Ferris SH, Alvarez XA, Laredo M, Moessler H (2005) Effects of N-PEP-12 on memory among older adults. Int Clin Psychopharmacol 20:97\u2013100. https:\/\/doi.org\/10.1097\/00004850-200503000-00006","journal-title":"Int Clin Psychopharmacol"},{"key":"4707_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1176\/appi.psy.43.5.386","volume":"43","author":"I Aben","year":"2002","unstructured":"Aben I, Verhey F, Lousberg R, Lodder J, Honig A (2002) Validity of the beck depression inventory, hospital anxiety and depression scale. Psychosomatics 43:386\u2013393. https:\/\/doi.org\/10.1176\/appi.psy.43.5.386","journal-title":"Psychosomatics"},{"key":"4707_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000355496","volume":"36","author":"ST Pendlebury","year":"2013","unstructured":"Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM (2013) Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke. Cerebrovasc Dis 36:355\u2013362. https:\/\/doi.org\/10.1159\/000355496","journal-title":"Cerebrovasc Dis"},{"key":"4707_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/neu.2014.3558","volume":"32","author":"W Poon","year":"2015","unstructured":"Poon W, Vos P, Muresanu D, Vester J, von Wild K, H\u00f6mberg V, Wang E, Lee TMC, Matula C (2015) Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods. J Neurotrauma 32:571\u2013580. https:\/\/doi.org\/10.1089\/neu.2014.3558","journal-title":"J Neurotrauma"},{"key":"4707_CR19","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/STROKEAHA.110.598540","volume":"42","author":"TJ Quinn","year":"2011","unstructured":"Quinn TJ, Langhorne P, Stott DJ (2011) Barthel index for stroke trials: development, properties, and application. Stroke 42:1146\u20131151. https:\/\/doi.org\/10.1161\/STROKEAHA.110.598540","journal-title":"Stroke"},{"key":"4707_CR20","doi-asserted-by":"publisher","unstructured":"Lenhard W, Lenhard A Calculation of effect sizes. Psychometrica. https:\/\/doi.org\/10.13140\/RG.2.2.17823.92329","DOI":"10.13140\/RG.2.2.17823.92329"},{"key":"4707_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","volume":"141","author":"CO Fritz","year":"2012","unstructured":"Fritz CO, Morris PE, Richler JJ (2012) Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141:2\u201318. https:\/\/doi.org\/10.1037\/a0024338","journal-title":"J Exp Psychol Gen"},{"key":"4707_CR22","volume-title":"Explaining psychological statistics","author":"B Cohen","year":"2014","unstructured":"Cohen B (2014) Explaining psychological statistics, 4th edn. Wiley, New York","edition":"4"},{"key":"4707_CR23","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale"},{"key":"4707_CR24","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley","DOI":"10.1002\/9780470743386"},{"key":"4707_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/bimj.201800107","volume":"61","author":"V Rahlfs","year":"2019","unstructured":"Rahlfs V, Zimmermann H (2019) Effect size measures and their benchmark values for quantifying benefit or risk of medicinal products. Biom J 61:973\u2013982. https:\/\/doi.org\/10.1002\/bimj.201800107","journal-title":"Biom J"},{"key":"4707_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/1747493017711816","volume":"12","author":"J Bernhardt","year":"2017","unstructured":"Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, Krakauer JW, Boyd LA, Carmichael ST, Corbett D, Cramer SC (2017) Agreed definitions and a shared vision for new standards in stroke recovery research: the Stroke Recovery and Rehabilitation Roundtable taskforce. Int J Stroke 12:444\u2013450. https:\/\/doi.org\/10.1177\/1747493017711816","journal-title":"Int J Stroke"},{"key":"4707_CR27","doi-asserted-by":"crossref","unstructured":"Muresanu DF (2008) Neuroplasticity and neurorecovery. pp 37\u201349","DOI":"10.1159\/000210271"},{"key":"4707_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40263-019-00663-x","volume":"33","author":"DF Muresanu","year":"2019","unstructured":"Muresanu DF, Strilciuc S, Stan A (2019) Current drug treatment of acute ischemic stroke: challenges and opportunities. CNS Drugs 33:841\u2013847. https:\/\/doi.org\/10.1007\/s40263-019-00663-x","journal-title":"CNS Drugs"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04707-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T20:14:58Z","timestamp":1633119298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4707"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04707-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments, recommendations of good clinical practice of the International Conference on Harmonization (2001\/20\/EEC, CPMP\/ICH\/135\/95). The study was approved on 10\/12\/2015, by the Ethics Committee of the Iuliu Hatieganu University of Medicine and Pharmacy (8 Babe\u015f Street, 400012 Cluj-Napoca, Romania), reference number 507\/10.12.2015, amended 82\/24\/03\/2016, 104\/12\/02\/2018. Amendments were submitted to adapt outcome scales prior to study initiation and to correct minor protocol inconsistencies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"An informed consent form was obtained from each participant of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}